NCT07140692View on ClinicalTrials.gov

EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Vitreous FloatersVitreous Opacities
Interventions
DEVICE

Vitrectomy

In this single-arm, non-comparative study, patients presenting with vitreous opacities affecting daily activities of living will undergo vitrectomy using the single-use vitrector probe of Vista Ophthalmics for the removal of the vitreous opacities.

Trial Locations (1)

53142

The Eye Centers of Racine & Kenosha, Kenosha

All Listed Sponsors
lead

The Eye Centers of Racine and Kenosha

OTHER

NCT07140692 - EFFECTIVENESS AND SAFETY ASSESSMENT OF THE VISTA VITRECTOMY PROBE | Biotech Hunter | Biotech Hunter